EX-99.5 7 prof-20231231xex99d5.htm EX-99.5

Exhibit 99.5

Certification

pursuant to

18 U.S.C. Section 1350

as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report on Form 40-F of Profound Medical Corp. (the “Company”) for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies pursuant to 18 U.S.C.§ 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his respective knowledge:

| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 7, 2024

​

​ | ​ | ​
​ |  | /s/Arun Menawat
​ | ​ | Arun Menawat
​ | ​ | Chief Executive Officer

​

Date: March 7, 2024

​

​ | ​ | ​
​ |  | /s/ Rashed Dewan
​ | ​ | Rashed Dewan
​ | ​ | Chief Financial Officer

​

This certificate has not been, and shall not be deemed to be, “filed” with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934.